Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Therapeuticendoscopists (gastroenterologists with specialized training in endoscopic procedures) utilize advanced diagnostic tools such as endoscopic ultrasound (EUS) in order to visualize the cyst and help identify which type it might be. Endoscopic ultrasound also allows fine needle aspiration of the cyst. This enables analysis with tumor markers and cytology to help diagnose the nature of the cyst, which is critical in developing an effective treatment plan.
In observing a pancreatic mass, EUS provides our specialists with the tools to examine the pancreas at very close distance, providing detailed information of the pancreatic mass. Utilizing EUS, we obtain tissue of the mass with fine needle aspiration. The tissue sample is then interpreted by our pathologists to help discriminate among the various causes of pancreatic masses.
In the event that pancreatic cancer is suspected, the Benign Pancreas Program and Stanford's world class Cancer Center collaborate closely to ensure a coordinated treatment strategy. Stanford's Benign Pancreas Program is uniquely qualified to treat both pancreatic cysts and pancreatic masses.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.